IL64839A - N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them - Google Patents
N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL64839A IL64839A IL64839A IL6483982A IL64839A IL 64839 A IL64839 A IL 64839A IL 64839 A IL64839 A IL 64839A IL 6483982 A IL6483982 A IL 6483982A IL 64839 A IL64839 A IL 64839A
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- methylanilino
- arylmethyl
- sulfamoyl
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Housing For Livestock And Birds (AREA)
- Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)
- Processing Of Solid Wastes (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813101960 DE3101960A1 (de) | 1981-01-22 | 1981-01-22 | "basisch substituierte anthranilsaeuren, verfahren zu ihrer herstellung und ihre verwendung" |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL64839A0 IL64839A0 (en) | 1982-03-31 |
| IL64839A true IL64839A (en) | 1985-11-29 |
Family
ID=6123119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL64839A IL64839A (en) | 1981-01-22 | 1982-01-22 | N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4406895A (fi) |
| EP (1) | EP0056970B1 (fi) |
| JP (1) | JPS57142961A (fi) |
| KR (1) | KR830009074A (fi) |
| AT (1) | ATE12390T1 (fi) |
| AU (1) | AU7971182A (fi) |
| CA (1) | CA1190937A (fi) |
| DE (2) | DE3101960A1 (fi) |
| DK (1) | DK153395B (fi) |
| ES (1) | ES508757A0 (fi) |
| FI (1) | FI820172L (fi) |
| GR (1) | GR74756B (fi) |
| HU (1) | HU189556B (fi) |
| IE (1) | IE51928B1 (fi) |
| IL (1) | IL64839A (fi) |
| NO (1) | NO820180L (fi) |
| NZ (1) | NZ199532A (fi) |
| PH (1) | PH19628A (fi) |
| PT (1) | PT74319B (fi) |
| YU (1) | YU15182A (fi) |
| ZA (1) | ZA82393B (fi) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5111049A (en) * | 1990-12-21 | 1992-05-05 | Santa Barbara Research Center | Remote fired RF getter for use in metal infrared detector dewar |
| SG164305A1 (en) * | 2004-02-20 | 2010-09-29 | Aventis Pharma Inc | Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation |
| SG11202110950XA (en) * | 2019-04-02 | 2021-10-28 | Fondazione St Italiano Tecnologia | Modulators of intracellular chloride concentration |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3346568A (en) * | 1961-09-14 | 1967-10-10 | Ciba Geigy Corp | 2-amino-5-sulfamyl-benzoic acid hydrazides |
| CH433378A (de) * | 1962-03-09 | 1967-04-15 | Ciba Geigy | Verfahren zur Herstellung neuer Anthranilsäurederivate |
| FR5466M (fi) * | 1965-06-14 | 1967-10-16 | ||
| US3565920A (en) * | 1966-12-29 | 1971-02-23 | Ciba Geigy Corp | 5-sulfamyl-anthranilic acids |
| US3678039A (en) * | 1967-04-27 | 1972-07-18 | Lincoln Harvey Werner | 4-trifluoromethyl-anthranilic acids |
| GB1260155A (en) * | 1969-04-29 | 1972-01-12 | Leo Pharm Prod Ltd | Sulphonamido anthranilic acid derivatives |
| BE768706A (fr) * | 1970-06-18 | 1971-12-20 | Leo Pharm Prod Ltd | Nouveaux acides sulfamoylbenzoiques |
| US3758522A (en) * | 1970-06-18 | 1973-09-11 | Leo Pharm Prod Ltd | Certain sulfamylbenzoic acids, esters thereof, and pharmaceutically acceptable salts thereof |
| DE2232457A1 (de) * | 1972-07-01 | 1974-01-10 | Boehringer Mannheim Gmbh | Neue 3-alkyl-4-sulfamoylanilinderivate |
| DE2453548A1 (de) * | 1973-09-07 | 1976-03-18 | Hoechst Ag | Substituierte aminobenzoesaeurederivate und verfahren zu ihrer herstellung |
| DE2406972C3 (de) * | 1974-02-14 | 1979-07-19 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von 5-Sulfamoylanthranilsäuren |
-
1981
- 1981-01-22 DE DE19813101960 patent/DE3101960A1/de not_active Withdrawn
-
1982
- 1982-01-15 ES ES508757A patent/ES508757A0/es active Granted
- 1982-01-19 AT AT82100335T patent/ATE12390T1/de active
- 1982-01-19 EP EP82100335A patent/EP0056970B1/de not_active Expired
- 1982-01-19 DE DE8282100335T patent/DE3262732D1/de not_active Expired
- 1982-01-20 GR GR67065A patent/GR74756B/el unknown
- 1982-01-20 HU HU82154A patent/HU189556B/hu unknown
- 1982-01-20 US US06/341,006 patent/US4406895A/en not_active Expired - Fee Related
- 1982-01-20 KR KR1019820000228A patent/KR830009074A/ko unknown
- 1982-01-20 FI FI820172A patent/FI820172L/fi not_active Application Discontinuation
- 1982-01-20 PH PH26764A patent/PH19628A/en unknown
- 1982-01-21 CA CA000394605A patent/CA1190937A/en not_active Expired
- 1982-01-21 ZA ZA82393A patent/ZA82393B/xx unknown
- 1982-01-21 YU YU00151/82A patent/YU15182A/xx unknown
- 1982-01-21 DK DK025982A patent/DK153395B/da not_active Application Discontinuation
- 1982-01-21 PT PT74319A patent/PT74319B/pt unknown
- 1982-01-21 AU AU79711/82A patent/AU7971182A/en not_active Abandoned
- 1982-01-21 JP JP57006887A patent/JPS57142961A/ja active Pending
- 1982-01-21 IE IE118/82A patent/IE51928B1/en unknown
- 1982-01-21 NO NO820180A patent/NO820180L/no unknown
- 1982-01-22 IL IL64839A patent/IL64839A/xx unknown
- 1982-06-20 NZ NZ199532A patent/NZ199532A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL64839A0 (en) | 1982-03-31 |
| PT74319B (de) | 1983-10-25 |
| FI820172L (fi) | 1982-07-23 |
| JPS57142961A (en) | 1982-09-03 |
| EP0056970B1 (de) | 1985-03-27 |
| NO820180L (no) | 1982-07-23 |
| KR830009074A (ko) | 1983-12-17 |
| DK25982A (da) | 1982-07-23 |
| PT74319A (de) | 1982-02-01 |
| ES8305319A1 (es) | 1983-04-01 |
| ZA82393B (en) | 1982-12-29 |
| DK153395B (da) | 1988-07-11 |
| HU189556B (en) | 1986-07-28 |
| US4406895A (en) | 1983-09-27 |
| YU15182A (en) | 1984-12-31 |
| PH19628A (en) | 1986-06-04 |
| ATE12390T1 (de) | 1985-04-15 |
| ES508757A0 (es) | 1983-04-01 |
| NZ199532A (en) | 1984-10-19 |
| AU7971182A (en) | 1982-07-29 |
| GR74756B (fi) | 1984-07-11 |
| EP0056970A1 (de) | 1982-08-04 |
| IE51928B1 (en) | 1987-04-29 |
| DE3262732D1 (en) | 1985-05-02 |
| IE820118L (en) | 1982-07-22 |
| CA1190937A (en) | 1985-07-23 |
| DE3101960A1 (de) | 1982-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL91753A0 (en) | 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acid,a process for the preparation thereof and pharmaceutical compositions containing them | |
| PT76336B (de) | Cephalosporinderivate und verfahren zu ihrer herstellung | |
| ES476106A1 (es) | Procedimiento para la preparacion de 4-espectinomicilamina. | |
| IL78691A0 (en) | Quinolylglycinamide derivatives,their preparation and pharmaceutical compositions containing them | |
| HUT51221A (en) | Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients | |
| DE3369983D1 (en) | Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| ES455691A1 (es) | Procedimiento para la produccion de derivados de piperacina. | |
| DE3063525D1 (en) | Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them | |
| IL91212A0 (en) | 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof,a process for the preparation thereof and pharmaceutical compositions containing them | |
| IL64839A (en) | N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them | |
| IE873212L (en) | Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor | |
| DE3378120D1 (en) | Thiazaspiro derivatives, process for their preparation and pharmaceutical composition | |
| IL87197A0 (en) | Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same | |
| IL87198A (en) | Leukotriene antagonists,a process for the preparation thereof and pharmaceutical compositions containing them | |
| ES8201152A1 (es) | Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos | |
| ES8201996A1 (es) | Procedimiento para la preparacion de acidos 2,4-diamino-5- sulfamoilbenzosulfonicos sustituidos | |
| EP0004261A3 (en) | Imidazole derivatives, method and intermediates for their preparation and pharmaceutical compositions containing such imidazole derivatives, as well as the use of such imidazole derivatives in combating diseases |